常规时段
					
										
  | 
									
										
  | 
									
										
  | 
									
										
  | 	
										
										
  | 
									
									
									
								||||||||||||
  | 
									
										
  | 
								
									
										
  | 
									
										
  | 
									
										
  | 
								
										
  | 
									
										
  | 
									
										
  | 
								
| 价值评估 | 
| 
										 盈利(现时/预测) 
										
												-21.39/-10.38										 
									 | 
								
| 
										 企业价值 
										
											3.82M										 
									 | 
								
| 资产负债 | 
| 
											 每股账面净值 
											
												3.67											 
										 | 
									
| 现金流量 | 
| 
											 现金流量率 	
											
																					--											 
										 | 
									
| 损益表 | 
| 
											 收益 
											 
													0											 
										 | 
									
| 
											 每股收益 
											
												--											 
										 | 
									
| 
	   					 同行比较 
	   					
	   				 | 
	   			||||||||||||||||||||||||||||||||||||||||||||||||
  | 
		   		
 
																报价延迟最少15分钟:2025/11/03 20:38 EST
														同行比较之报价最少15分钟延迟
											| 
						 业务概览 
					 | 
				|||
| Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. | 

				
						
 2.045														
